Market Research Logo

Global Novel Drug Delivery Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Global Novel Drug Delivery Systems Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.

Scope of the Report:

This report focuses on the Novel Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.

North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.

The worldwide market for Novel Drug Delivery Systems is expected to grow at a CAGR of roughly 2.2% over the next five years, will reach 30300 million US$ in 2023, from 26500 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen

Teva

UCB (Union Chimique Belge)

Roche

Celgene

Sanofi

Merck

Johnson & Johnson

Takeda

Gilead Sciences

Pfizer

Dr Reddy

Samyang Biopharmaceuticals

TOLMAR

Astellas

AMAG Pharmaceuticals

AstraZeneca

AbbVie

Bausch&Lomb

TWi Pharmaceuticals

Novartis

Aspen

Shire

Breckenridge Pharmaceuticals

Galen

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Liposomes

PEGylated Proteins & Polypeptides

Polymer Nanoparticle

Protein–drug Conjugates

Others

Market Segment by Applications, can be divided into

Hospitals & Clinic

Cancer Treatment Centers

Others

There are 15 Chapters to deeply display the global Novel Drug Delivery Systems market.

Chapter 1, to describe Novel Drug Delivery Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Novel Drug Delivery Systems, with sales, revenue, and price of Novel Drug Delivery Systems, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Novel Drug Delivery Systems, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Novel Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Novel Drug Delivery Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


1 Market Overview
1.1 Novel Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Liposomes
1.2.2 PEGylated Proteins & Polypeptides
1.2.3 Polymer Nanoparticle
1.2.4 Protein–drug Conjugates
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals & Clinic
1.3.2 Cancer Treatment Centers
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Novel Drug Delivery Systems Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Teva
2.2.1 Business Overview
2.2.2 Novel Drug Delivery Systems Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 UCB (Union Chimique Belge)
2.3.1 Business Overview
2.3.2 Novel Drug Delivery Systems Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Roche
2.4.1 Business Overview
2.4.2 Novel Drug Delivery Systems Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celgene
2.5.1 Business Overview
2.5.2 Novel Drug Delivery Systems Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Novel Drug Delivery Systems Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Novel Drug Delivery Systems Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.2 Novel Drug Delivery Systems Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Takeda
2.9.1 Business Overview
2.9.2 Novel Drug Delivery Systems Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Gilead Sciences
2.10.1 Business Overview
2.10.2 Novel Drug Delivery Systems Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Novel Drug Delivery Systems Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Dr Reddy
2.12.1 Business Overview
2.12.2 Novel Drug Delivery Systems Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Dr Reddy Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Samyang Biopharmaceuticals
2.13.1 Business Overview
2.13.2 Novel Drug Delivery Systems Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 TOLMAR
2.14.1 Business Overview
2.14.2 Novel Drug Delivery Systems Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 TOLMAR Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Astellas
2.15.1 Business Overview
2.15.2 Novel Drug Delivery Systems Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Astellas Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 AMAG Pharmaceuticals
2.16.1 Business Overview
2.16.2 Novel Drug Delivery Systems Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 AstraZeneca
2.17.1 Business Overview
2.17.2 Novel Drug Delivery Systems Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 AstraZeneca Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 AbbVie
2.18.1 Business Overview
2.18.2 Novel Drug Delivery Systems Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 AbbVie Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Bausch&Lomb
2.19.1 Business Overview
2.19.2 Novel Drug Delivery Systems Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Bausch&Lomb Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 TWi Pharmaceuticals
2.20.1 Business Overview
2.20.2 Novel Drug Delivery Systems Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 TWi Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Novartis
2.21.1 Business Overview
2.2.2 Novel Drug Delivery Systems Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Novartis Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Aspen
2.22.1 Business Overview
2.22.2 Novel Drug Delivery Systems Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Aspen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Shire
2.23.1 Business Overview
2.23.2 Novel Drug Delivery Systems Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Shire Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Breckenridge Pharmaceuticals
2.24.1 Business Overview
2.24.2 Novel Drug Delivery Systems Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.25 Galen
2.25.1 Business Overview
2.25.2 Novel Drug Delivery Systems Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Galen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Novel Drug Delivery Systems Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Novel Drug Delivery Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Novel Drug Delivery Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Novel Drug Delivery Systems Manufacturer Market Share in 2017
3.3.2 Top 6 Novel Drug Delivery Systems Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Novel Drug Delivery Systems Market Analysis by Regions
4.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Regions
4.1.1 Global Novel Drug Delivery Systems Sales and Market Share by Regions (2013-2018)
4.1.2 Global Novel Drug Delivery Systems Revenue and Market Share by Regions (2013-2018)
4.2 North America Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.3 Europe Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.5 South America Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5 North America Novel Drug Delivery Systems by Countries
5.1 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
5.1.1 North America Novel Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
5.1.2 North America Novel Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
5.2 United States Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.3 Canada Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.4 Mexico Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6 Europe Novel Drug Delivery Systems by Countries
6.1 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe Novel Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Novel Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
6.2 Germany Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.3 UK Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.4 France Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.5 Russia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.6 Italy Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7 Asia-Pacific Novel Drug Delivery Systems by Countries
7.1 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Novel Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
7.2 China Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.3 Japan Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.4 Korea Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.5 India Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8 South America Novel Drug Delivery Systems by Countries
8.1 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
8.1.1 South America Novel Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
8.1.2 South America Novel Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.3 Argentina Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.4 Colombia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9 Middle East and Africa Novel Drug Delivery Systems by Countries
9.1 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Novel Drug Delivery Systems Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Novel Drug Delivery Systems Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.3 UAE Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.4 Egypt Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.5 Nigeria Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.6 South Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
10 Global Novel Drug Delivery Systems Market Segment by Type
10.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Novel Drug Delivery Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
10.2 Liposomes Sales Growth and Price
10.2.1 Global Liposomes Sales Growth (2013-2018)
10.2.2 Global Liposomes Price (2013-2018)
10.3 PEGylated Proteins & Polypeptides Sales Growth and Price
10.3.1 Global PEGylated Proteins & Polypeptides Sales Growth (2013-2018)
10.3.2 Global PEGylated Proteins & Polypeptides Price (2013-2018)
10.4 Polymer Nanoparticle Sales Growth and Price
10.4.1 Global Polymer Nanoparticle Sales Growth (2013-2018)
10.4.2 Global Polymer Nanoparticle Price (2013-2018)
10.5 Protein–drug Conjugates Sales Growth and Price
10.5.1 Global Protein–drug Conjugates Sales Growth (2013-2018)
10.5.2 Global Protein–drug Conjugates Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Novel Drug Delivery Systems Market Segment by Application
11.1 Global Novel Drug Delivery Systems Sales Market Share by Application (2013-2018)
11.2 Hospitals & Clinic Sales Growth (2013-2018)
11.3 Cancer Treatment Centers Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Novel Drug Delivery Systems Market Forecast (2018-2023)
12.1 Global Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 Novel Drug Delivery Systems Market Forecast by Regions (2018-2023)
12.2.1 North America Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.2 Europe Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.4 South America Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa Novel Drug Delivery Systems Market Forecast (2018-2023)
12.3 Novel Drug Delivery Systems Market Forecast by Type (2018-2023)
12.3.1 Global Novel Drug Delivery Systems Sales Forecast by Type (2018-2023)
12.3.2 Global Novel Drug Delivery Systems Market Share Forecast by Type (2018-2023)
12.4 Novel Drug Delivery Systems Market Forecast by Application (2018-2023)
12.4.1 Global Novel Drug Delivery Systems Sales Forecast by Application (2018-2023)
12.4.2 Global Novel Drug Delivery Systems Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report